Meropenem Injection, Powder, For Solution
Product Images NDC 63323-507

6 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 63323-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mer0a 0001 01

Mer0a 0001 01
Chemical structure of Meropenem, showing its characteristic beta-lactam ring, sulfur-containing five-membered ring, and other functional groups including a carboxylic acid and dimethylamide substituent, with three molecules of water of hydration indicated.*
FDA Label Image

Mer0a 0001 02

FDA Label Image

Mer0a 0001 03

Mer0a 0001 03
Label for Meropenem Injection, USP (I.V.), equivalent to 500 mg meropenem per vial. This sterile single-dose vial contains meropenem powder for intravenous use only, with sodium content approximately 45.1 mg. The label highlights the 500 mg strength and specifies it is for prescription use only, manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Mer0a 0001 04

Mer0a 0001 04
Meropenem for Injection, USP (I.V.) 500 mg/vial powder for solution label. The packaging indicates Meropenem equivalent to 500 mg per vial, supplied as 10 sterile single-dose vials for intravenous use only. Labeler is novaplus, a Fresenius Kabi USA brand. The label includes the NDC 63323-507-21.*
FDA Label Image

Mer0a 0001 05

Mer0a 0001 05
Label for Meropenem Injection USP (I.V.), 1 gram per vial, sterile single-dose vial for intravenous use. The label includes the strength as 1 gram of meropenem activity per vial and mentions sodium content. The product is marked Rx only and labeled with Novaplus trademark of Vizient, Inc.*
FDA Label Image

Mer0a 0001 06

Mer0a 0001 06
Meropenem for Injection, USP (I.V.), 1 gram per vial, powder for solution, sterile single-dose vials. The label states this product is for intravenous use only and includes 10 vials per package. Labeler is Novaplus, with NDC 63323-508-31 visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.